Wellgistics Health, Inc.
WGRX
$3.05
$0.196.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -51.59% | 27.55% | 478.87% | 17,148.17% | 17,106.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -51.59% | 27.55% | 478.87% | 17,148.17% | 17,106.05% |
| Cost of Revenue | -20.92% | 81.92% | 503.87% | 71,598.94% | -- |
| Gross Profit | -382.48% | -463.63% | 416.41% | 114,265.38% | -- |
| SG&A Expenses | 21.58% | 952.65% | 1,944.70% | 1,528.89% | 1,183.69% |
| Depreciation & Amortization | 44.20% | 188.09% | 553.77% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.26% | 330.63% | 1,057.46% | 2,870.91% | 2,145.88% |
| Operating Income | -49.31% | -1,221.30% | -1,985.89% | -1,517.80% | -1,165.34% |
| Income Before Tax | -95.35% | -1,377.12% | -2,059.46% | -1,618.01% | -1,217.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -95.35% | -1,377.12% | -2,059.46% | -1,618.01% | -1,217.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -95.35% | -1,377.12% | -2,059.46% | -1,618.01% | -1,217.69% |
| EBIT | -49.31% | -1,221.30% | -1,985.89% | -1,517.80% | -1,165.34% |
| EBITDA | -49.56% | -1,473.17% | -3,620.86% | -6,894.99% | -- |
| EPS Basic | -21.88% | -945.93% | -1,565.90% | -1,366.77% | -1,557.67% |
| Normalized Basic EPS | -0.59% | -829.43% | -1,542.27% | -1,366.84% | -1,557.69% |
| EPS Diluted | -21.88% | -945.93% | -1,565.90% | -1,366.77% | -1,557.67% |
| Normalized Diluted EPS | -0.59% | -829.43% | -1,542.27% | -1,366.84% | -1,557.69% |
| Average Basic Shares Outstanding | 72.99% | 51.55% | 28.90% | 17.11% | 45.35% |
| Average Diluted Shares Outstanding | 72.99% | 51.55% | 28.90% | 17.11% | 45.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |